Advertisement

Topics

Indivior signs schizophrenia drug deal with HLS

06:03 EDT 10 May 2019 | SmartBrief

Indivior has entered a licensing deal with HLS Therapeutics to sell the schizophrenia drug Perseris in Canada. -More

Original Article: Indivior signs schizophrenia drug deal with HLS

NEXT ARTICLE

More From BioPortfolio on "Indivior signs schizophrenia drug deal with HLS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...